Percutaneous transcatheter infusion and infarction in the treatment of human cancer: Part II.
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000188:drug therapy / Q000628:therapy; D001932:Brain Neoplasms / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D004621:Embolization, Therapeutic / Q000379:methods; D005260:Female; D005870:Giant Cell Tumors / Q000628:therapy; D006258:Head and Neck Neoplasms / Q000628:therapy; D018219:Histiocytoma, Benign Fibrous / Q000628:therapy; D006801:Humans; D007261:Infusions, Intra-Arterial; D008297:Male; D008545:Melanoma / Q000188:drug therapy; D008875:Middle Aged; D009303:Nasopharyngeal Neoplasms / Q000628:therapy; D009369:Neoplasms / Q000188:drug therapy / Q000628:therapy*; D012516:Osteosarcoma / Q000188:drug therapy; D012878:Skin Neoplasms / Q000188:drug therapy; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy; D014846:Vulvar Neoplasms / Q000188:drug therapy
D000970:Antineoplastic Agents